# Pre-Operative Radiation and Veliparib for Breast Cancer

> **NCT01618357** · PHASE1 · COMPLETED · sponsor: **Richard Zellars** · enrollment: 19 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **RADIATION:** Radiation
- **PROCEDURE:** Lumpectomy/Mastectomy
- **DRUG:** Veliparib

## Key facts

- **NCT ID:** NCT01618357
- **Lead sponsor:** Richard Zellars
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07-22
- **Primary completion:** 2023-09-06
- **Final completion:** 2023-10-17
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2024-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01618357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01618357, "Pre-Operative Radiation and Veliparib for Breast Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01618357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*